Cleaved high-molecular-weight kininogen and its domain 5 inhibit migration and invasion of human prostate cancer cells through the epidermal growth factor receptor pathway

Medicine & Life Sciences

• High Molecular Weight Kininogens 100%
• Urokinase Plasminogen Activator Receptors 64%
• ErbB Receptors 61%
• Prostatic Neoplasms 51%
• Fibroblast Growth Factor 2 19%
• Plasma Kallikrein 13%
• Phosphorylation 12%
• Bradykinin 10%
• Extracellular Signal-Regulated MAP Kinases 10%
• Immunoblotting 9%
• Immunoprecipitation 9%
• Integrins 8%
• Cluster Analysis 8%
• Vascular Endothelial Growth Factor A 7%
• Cell Movement 7%
• Up-Regulation 6%
• Neoplasms 5%
• Neoplasm Metastasis 5%
• Therapeutics 1%